http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003513281-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-567 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2000-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2003513281-A |
| titleOfInvention | Use of membranes, cells and tissues from the last field to identify therapeutic compounds |
| abstract | (57) [Summary]nThe present invention relates to the use of membranes, cells and / or tissues from the last field and / or their adjacent sections by various means to identify physiologically active substances, for example substances having activity on food homeostasis. About. More particularly, the present invention relates to a method for identifying agonists and antagonists of endogenous biological activity, wherein the candidate compound is used in certain biological preparations containing endogenous and / or adjacent brain components. Including assessing the ability to bind. In addition, the present invention relates to preparations made from material derived from brain tissue adjacent to the last cortex, including material from any part of the solitary nucleus and / or the dorsal motor nucleus of the vagus nerve. |
| priorityDate | 1999-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 375.